Clinical Trial Update: Real-world Comparative Effectiveness of Rivaroxaban Versus VKA

View source ↗

Summary

Real-world study comparing rivaroxaban with vitamin K antagonists for atrial fibrillation, reporting comparative effectiveness results from a completed trial.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Warfarin (warfarin)
• Xarelto (rivaroxaban)

Snippet

Sponsor: Bayer | Conditions: Atrial Fibrillation | Status: COMPLETED